Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Elkhart
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Elkhart, IN

Studies commonly pay $75 to $4,500 per completed study

113 clinical trials are currently recruiting participants within 30 miles of Elkhart. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

113studies recruiting
8+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Elkhart right now

Top 25 of 113 recruiting studies, sorted by proximity — each links to its official registry page

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05136196)

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

Respiratory Distress Syndrome, Pre-term Infants Phase 3 Interventional 520 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi) · Sponsor: Aerogen Pharma Limited
See eligibility & contact on ClinicalTrials.gov (NCT06776783)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Elkhart General Hospital — Elkhart, Indiana (1.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma Phase 3 Interventional 62 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05235165)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05896189)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Memorial Regional Cancer Center Day Road — Mishawaka, Indiana (10.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought
Akero Clinical Study Site — South Bend, Indiana (14.8 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06215716)

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain Phase 3 Interventional 200 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04804644)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06876714)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Phase 3 Interventional 304 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06096844)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,000 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05334069)

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm N/A Observational 5,000 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute LAO
See eligibility & contact on ClinicalTrials.gov (NCT02474160)

The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families

Mental Health, Conflict N/A Interventional 1,800 participants sought
University of Notre Dame — Notre Dame, Indiana (14.2 mi) · Sponsor: University of Notre Dame
See eligibility & contact on ClinicalTrials.gov (NCT04980794)

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus, T2DM Phase 2 Interventional 180 participants sought
The South Bend Clinic — South Bend, Indiana (14.8 mi) · Sponsor: Hanmi Pharmaceutical Company Limited
See eligibility & contact on ClinicalTrials.gov (NCT07527650)

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

Aortic Stenosis, Coronary Artery Disease N/A Interventional 4,000 participants sought
Midwest Cardiovascular Research and Education Foundation — Elkhart, Indiana (1.0 mi) · Sponsor: University of British Columbia
See eligibility & contact on ClinicalTrials.gov (NCT04634240)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05987241)
Google-rated

Top-rated research centers in Elkhart

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Indiana Medical Research

303 S Nappanee St, Elkhart, IN 46514
(574) 296-3200

Center for Rare and Neglected Diseases

18885 Moose Krause Cir Galvin Life Sciences Center, Notre Dame, IN 46556
(574) 631-8831

Digestive Research Alliance of Michiana

★ 5.0
53830 Generations Dr Ste 110, South Bend, IN 46635
(574) 393-9755

Velocity Clinical Research

★ 4.5
55 University Dr Ste 106, Valparaiso, IN 46383
(219) 464-8302
"Do go there, 2 minutes to load a card, after you done your part, I say because I'm black."
— Crystal Washington, 1★

LūM Granger

★ 4.8
7221 N Fir Rd, Granger, IN 46530
(574) 968-5166
"These people are some of the most friendly, caring professionals I’ve encountered. Thank you so much"
— Lisa Harkins, 5★

Medical Behavioral Hospital of Mishawaka

★ 2.2 (122 reviews)
1625 E Jefferson Blvd, Mishawaka, IN 46545
(574) 255-1400
"Im not very happy about my "made up" diagnosis. I would like it reversed.<br><br>7 days."
— Richard Hemenway, 1★

Goshen Center for Cancer Care

★ 3.8 (33 reviews)
200 High Park Ave, Goshen, IN 46526
(574) 364-2888
"Dr. Schilder is the best! He keeps my spirits up with his quirky little statements, like Chatty Kathy, he's just the absolute best Dr and I consider …"
— Kathy Hite, 5★

Notre Dame Clinical Law Center

★ 3.5
725 Howard St, South Bend, IN 46617
(574) 631-7795
"It’s just not all it’s cracked up to be . They may and may not help."
— Glen Smarr, 2★

Clinical trials in Elkhart: what's recruiting

The Elkhart area currently has 113 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Elkhart, the most active research areas are:

  • Cancer & Oncology18 studies
  • Liver & Kidney3 studies
  • Lungs & Breathing1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Elkhart, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Elkhart

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Elkhart participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Elkhart?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Elkhart?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Elkhart?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Elkhart.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Elkhart typically complete one or two studies per year.

Paid clinical trials near Elkhart

Other metros within reach

South Bend, IN113 Kalamazoo, MI109 Fort Wayne, IN112 Grand Rapids, MI455 Muskegon, MI61 Lafayette, IN40 Chicago, IL2,449 Lansing, MI185

More of IN

Indianapolis915 South Bend113 Fort Wayne112 Evansville67 Lafayette40

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts